Thousand Oaks Biopharmaceuticals

Thousand Oaks Biopharmaceuticals

Thousand Oaks Biopharmaceuticals

Thousand Oaks Biopharmaceuticals is a clinicalstage biotech company.
Type
B2c
Founded
2017
Raised
$107.6M
Follow us
Alexa global traffic share
Latest funding
$64,000,000
Venture capital (Series B) - 2020
CICC Jiatai Fund Goldstone Investment Limited
CNY ¥300,000,000
Venture capital (Series A) - 2019
Addor Capital New Alliance Capital TenYall&a;Sumin Investment Management +3
Team Size
1–10
Employees
Location
Headquarters
$64,000,000 Venture capital (Series B)
DealStreetAsia

Biopharma firm Thousand Oaks raises $64m led by CICC fund, Goldstone

CNY ¥300,000,000 Venture capital (Series A)
ChinaMoneyNetwork

Chinese Drug Maker Thousand Oaks Biopharmaceuticals Nets $44M In Series A Round